MediWound (MDWD) Depreciation & Amortization (CF) (2013 - 2025)
MediWound (MDWD) recorded quarterly Depreciation & Amortization (CF) of -$690000.0 in Q4 2025, down 65.07% quarter-over-quarter from -$418000.0 in Q3 2025, and down 73.8% on a YoY basis from -$2.6 million in Q4 2024.
MediWound (MDWD) Depreciation & Amortization (CF) (2013 - 2025) Analysis & Trends
MediWound's Depreciation & Amortization (CF) history runs 13 years deep, the most recent figure standing at -$690000.0 for Q4 2025.
- In Q4 2025, Depreciation & Amortization (CF) fell 73.8% year-over-year to -$690000.0; the TTM figure through Dec 2025 stood at -$356000.0 (down 657.45% YoY), while the FY2025 annual figure was $1.9 million, up 225.42% from the prior year.
- Depreciation & Amortization (CF) was -$690000.0 for Q4 2025 at MediWound, down from -$418000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $394000.0 in Q2 2025 to a low of -$690000.0 in Q4 2025.
- Historically, Depreciation & Amortization (CF) has averaged $75150.0 across 5 years, with a median of $317000.0 in 2021.
- The sharpest annual moves came in 2021 and 2022: Depreciation & Amortization (CF) slumped 223.21% in 2021, then soared 202.9% in 2022.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at -$276000.0 in 2021, then jumped by 202.9% to $284000.0 in 2022, then plunged by 221.83% to -$346000.0 in 2023, then fell by 14.74% to -$397000.0 in 2024, then slumped by 73.8% to -$690000.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at -$690000.0 (Q4 2025), -$418000.0 (Q3 2025), and $394000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 429,663.65 |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | -690,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -690,000.00 |
| Dec 31, 2025 | -690,000.00 |
| Sep 30, 2025 | -418,000.00 |
| Sep 30, 2025 | -418,000.00 |
| Jun 30, 2025 | 394,000.00 |
| Jun 30, 2025 | 394,000.00 |
| Mar 31, 2025 | 358,000.00 |
| Mar 31, 2025 | 358,000.00 |
| Dec 31, 2024 | -397,000.00 |
| Dec 31, 2024 | -397,000.00 |
| Sep 30, 2024 | 361,000.00 |
| Sep 30, 2024 | 361,000.00 |
| Jun 30, 2024 | 357,000.00 |
| Jun 30, 2024 | 357,000.00 |
| Mar 31, 2024 | -368,000.00 |
| Mar 31, 2024 | -368,000.00 |
| Dec 31, 2023 | -346,000.00 |
| Dec 31, 2023 | -346,000.00 |
| Sep 30, 2023 | 339,000.00 |
| Sep 30, 2023 | 339,000.00 |